Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,397,881 | 4,410,581 | +12,700 | $84.31M | $69.25M | 62.35% | -$15.06M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 2,111,919 | +2,111,919 | $0 | $23.25M | 20.93% | +$23.25M |
| Lyell Immunopharma, Inc.(LYEL) | 8,325,000 | 16,007,999 | +7,682,999 | $5.33M | $8.61M | 7.75% | +$3.28M |
| Kura Oncology, Inc.(KURA) | 1,726,882 | 1,111,882 | -615,000 | $15.04M | $7.34M | 6.61% | -$7.70M |
| Relay Therapeutics, Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | $4.12M | $2.62M | 2.36% | -$1.50M |